Accro Bioscience Inc.
PrivateLast Round
Series C
May 18, 2026
Total Funding Raised
$112M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Accro Bioscience Inc. is a biotechnology company that pioneers the discovery, development, and commercialization of novel therapeutics for inflammatory and autoimmune diseases by targeting molecular mechanisms of regulatory cell death.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accro Bioscience Inc. Comparables
Compare Accro Bioscience Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncodesign Precision Medicine | 81% | |
| Alumis | 79% | |
| Sareum Holdings plc | 78% |
Accro Bioscience Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2026 | ||||
| Series B Extension | Mar 14, 2025 | ||||
| Series B | Jan 4, 2022 | ||||
| Series A | Sep 1, 2017 |
Accro Bioscience Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TCG Crossover | Series C |
| Oriza Holdings | Series C, Series B |
| Morningside Ventures | Series B Extension, Series A |
| OrbiMed | Series C |
| 中南创投基金 | Series B |
| TCG Crossover | Series C |
| Cenova Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$50M round led by OrbiMed
- Mar 3, 2026
Monthly visitors increased 41% MoM.
Accro Bioscience Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accro Bioscience Inc.'s valuation, stock price, and market status.
Is Accro Bioscience Inc. a public or private company?
Accro Bioscience Inc. is a private company.
What is the current stock price of Accro Bioscience Inc.?
Accro Bioscience Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Accro Bioscience Inc. worth (valuation)?
Valuation information for Accro Bioscience Inc. is not publicly available.
Can I buy Accro Bioscience Inc. stock?
Accro Bioscience Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Accro Bioscience Inc.'s last funding round?
Accro Bioscience Inc.'s most recent funding round was Series C on May 18, 2026.
Who are the main investors in Accro Bioscience Inc.?
Key investors in Accro Bioscience Inc. include Morningside Ventures, OrbiMed, Hongtai Aplus, Shenzhen Capital Group.
Will Accro Bioscience Inc. IPO soon?
No public IPO plans have been announced for Accro Bioscience Inc..
How can I track Accro Bioscience Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Accro Bioscience Inc.'s secondary market activity and sign up for updates.